Correlation Between India Glycols and Entero Healthcare

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both India Glycols and Entero Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining India Glycols and Entero Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between India Glycols Limited and Entero Healthcare Solutions, you can compare the effects of market volatilities on India Glycols and Entero Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in India Glycols with a short position of Entero Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of India Glycols and Entero Healthcare.

Diversification Opportunities for India Glycols and Entero Healthcare

0.77
  Correlation Coefficient

Poor diversification

The 3 months correlation between India and Entero is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding India Glycols Limited and Entero Healthcare Solutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Healthcare and India Glycols is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on India Glycols Limited are associated (or correlated) with Entero Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Healthcare has no effect on the direction of India Glycols i.e., India Glycols and Entero Healthcare go up and down completely randomly.

Pair Corralation between India Glycols and Entero Healthcare

Assuming the 90 days trading horizon India Glycols Limited is expected to under-perform the Entero Healthcare. In addition to that, India Glycols is 1.1 times more volatile than Entero Healthcare Solutions. It trades about -0.08 of its total potential returns per unit of risk. Entero Healthcare Solutions is currently generating about -0.06 per unit of volatility. If you would invest  134,380  in Entero Healthcare Solutions on November 27, 2024 and sell it today you would lose (6,615) from holding Entero Healthcare Solutions or give up 4.92% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

India Glycols Limited  vs.  Entero Healthcare Solutions

 Performance 
       Timeline  
India Glycols Limited 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days India Glycols Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, India Glycols is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.
Entero Healthcare 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Entero Healthcare Solutions has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Entero Healthcare is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

India Glycols and Entero Healthcare Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with India Glycols and Entero Healthcare

The main advantage of trading using opposite India Glycols and Entero Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if India Glycols position performs unexpectedly, Entero Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Healthcare will offset losses from the drop in Entero Healthcare's long position.
The idea behind India Glycols Limited and Entero Healthcare Solutions pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories